Navigation Links
Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
Date:10/17/2007

p=0.012 for per protocol populations). While in this exploratory study this endpoint was identified as a secondary end point, FDA currently requires the absolute change (rather than percent change) in the number of inflammatory lesions as one of the co-primary endpoints, along with Treatment Success, for demonstrating efficacy in a Phase III trial in rosacea.

"Based on these encouraging results, we have selected once-daily Omiganan 2.5% for further study in rosacea, which is a critical step towards potential commercialization, either directly or in collaboration with a partner," commented Robert J. Bitterman, President and CEO of Cutanea.

About Rosacea

Rosacea is a chronic dermatologic disorder with no current cure and a poorly understood etiology that afflicts an estimated 14 million Americans. Symptoms primarily manifest on the facial skin and include facial flushing, central facial inflammatory lesions, and facial erythema. According to surveys conducted by the National Rosacea Society (NRS), nearly 70% of rosacea patients said the disorder had lowered their self-confidence and self-esteem; 41% reported it had caused them to avoid public contact or cancel social engagements; and nearly 30% claimed to have missed work due to rosacea. Of these rosacea patients surveyed by the NRS that sought medical treatment, over 70 percent reported an improvement in their emotional and social well-being.

Typical onset of rosacea occurs between 30 and 50 years of age and is more prevalent in women than men. Clearing up the initial outbreak is only the beginning, as rosacea is characterized by periods of relapses and remissions. Relapse episodes can be spurred by sun exposure, stress, hot or cold weather, alcohol, spicy foods, exercise, and certain skin care products and medications.

Absent a cure for rosacea, treatment is aimed at alleviating the disorder's symptoms. Topical or oral medications are generally prescribed for mild to moderate papulopus
'/>"/>

SOURCE Cutanea Life Sciences
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... FRANCISCO , May 18, 2013 ... MadinAmerica.com , Occupy Psychiatry , ... mental health care, announces a social media campaign ... the traditional psychiatric model, which focuses on pathology ... launch coincides with the American Psychiatric Association,s (APA) ...
(Date:5/17/2013)... May 17, 2013 The power of plants ... ways in which mankind depends on the plant kingdom, ... multifaceted exhibition Wild Medicine: Healing Plants ... on view from May 18 through September 8, 2013. ... The featured exhibition,s many attractions include a re-creation of ...
(Date:5/17/2013)... 2013  Lakeland Industries, Inc. (NASDAQ: LAKE ... industry, healthcare and to first responders on the federal, ... for the fiscal 2013 fourth quarter and year ended ... stock market close and will conduct a conference call ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
... Sanofi Pasteur, the vaccines division of the sanofi-aventis Group ... today that the U.S. Food and Drug Administration (FDA) ... meningococcal conjugate vaccine, Menactra® (Meningococcal [Groups A, C, Y ... a two-dose schedule for infants and children 9 months ...
... N.C., April 22, 2011 The growing importance of ... to manage rapidly changing regulatory requirements in today,s biopharmaceutical ... companies anticipate an increase in medical affairs funding of ... on the minds of medical affairs executives is insufficient ...
Cached Medicine Technology:Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 2Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 3Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 4Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 5Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing 2
(Date:5/19/2013)... 2013 Healthcare leaders will gather at ... the Walt Disney World Swan and Dolphin in Orlando, ... innovation, care delivery and healthcare reform and implementation. , ... healthcare markets, with consolidation, efficiency and reduced ... Todd Ebert, Amerinet president and CEO. “There is a ...
(Date:5/19/2013)... People in Minnesota have a great option to get ... 28 Day Fat Loss Formula. The best part is ... own home. The product sells for $135 dollars and is ... here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. ... after using the 28 Day Fat Loss Formula they will ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Actos ... federal litigation now underway in U.S. District Court, Western ... Order dated May 3rd, the Court has modified the ... to eight cases rather than four. The next Status ... Thursday, May 23rd. (In re: Actos Product Liability Litigation, ...
(Date:5/19/2013)... Utah (PRWEB) May 19, 2013 ... on small business health insurance . Zane ... traditional employer sponsored health benefits, is the leader ... and health reimbursement arrangements . , According ... and the self-employed intrinsically know the value of ...
(Date:5/19/2013)... According to a new market research report "Image ... By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), Surveillance, Automobile, ... Infrared, X-Ray) And Geography" published by MarketsandMarkets, the ... in 2012 and is expected to reach $10.75 ... 3.84% from 2013 to 2018. In terms of ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3
... Funds to Improve Care and Protection of Migrant Children in South ... 2 Not On Our Watch, the international advocacy and aid ... , Matt Damon , Brad Pitt , producer ... has awarded the U.S. Fund for UNICEF a grant of $438,000 ...
... of Leicester and published this week in the British Journal ... receiving inferior care for their medical needs. The study ... from the University of Leicester Department of Cancer Studies and ... of medicine to those with a mental health or substance ...
... access laparoscopic surgery , , MIAMI, June 2 ... company, announced today that it has received 510(k) clearance ... the InnoPort(TM) to facilitate single port access laparoscopy. ... the abdomen to perform laparoscopic surgery through one small ...
... ... National Smile Month, and the Hispanic Dental Association (HDA), Oral Health America, and participating ... not to forget their toothbrushes on summer vacation. National Smile Month promotes the ... Brushing teeth twice a day with fluoride toothpaste , ...
... ... Life Support and Pediatric Advanced Life Support training. , ... Lincoln, NE (Vocus) June 2, ... a top-tier school in Lincoln, Nebraska, recently developed and launched an exclusive, interactive ...
... , Abbott Expands ZonePerfect Nutrition Bar Line to Meet Demand for ... June 2 (NYSE: ABT ) - Fueled by ... today announced the introduction of three new flavors of ... Pecan, Dark Chocolate Mocha and Dark Chocolate Cookies N, Creme. ...
Cached Medicine News:Health News:Not On Our Watch Grant to UNICEF to Support Critical Protection Programs for Zimbabwean Refugee Children 2Health News:Not On Our Watch Grant to UNICEF to Support Critical Protection Programs for Zimbabwean Refugee Children 3Health News:New study shows people with mental health problems receive inadequate medical care 2Health News:Innovia Receives FDA Clearance For The InnoPort(TM) 2Health News:Hispanic Dental Association and Oral Health America Celebrate National Smile Month, June 1-30 2Health News:Health Education Solutions Launches Online Certification Programs for Critical Care Medical Professionals 2Health News:Health Education Solutions Launches Online Certification Programs for Critical Care Medical Professionals 3Health News:Three New ZonePerfect(R) Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 2Health News:Three New ZonePerfect(R) Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 3Health News:Three New ZonePerfect(R) Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking 4
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves....
... range of fixed curve catheters designed to ... and other patients with small anatomies. Each ... only the finest materials. A unique multi-step ... extrusion technologies results in the excellent torque ...
... To aid clinicians in performing Ankle/Brachial Index ... new, complete packet of information. It includes ... that can be viewed on any computer ... step-by-step procedure of performing an ABI test, ...
... VERICIS PhysioLog Hemodynamic Monitoring and Data ... system for the cath lab, integrating ... Waveform analysis , Data collection , ... Image capture/analysis , Procedural reporting ...
Medicine Products: